Jacobus J. Bosch

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2

Peter G. Kremsner, Philipp Mann, Arne Kroidl et al. · Wiener klinische Wochenschrift · 2021 · 130 citations · Full text

Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers

Peter G. Kremsner, Philipp Mann, Jacobus J. Bosch et al. · 2020 · 103 citations · Full text

Candidate Vaccine Cvncov, Viral Immunity, Immunology +17

Lung cancer patients’ CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells

Minu K. Srivastava, Jacobus J. Bosch, James A. Thompson et al. · Cancer Immunology Immunotherapy · 2008 · 99 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Immunology +10

Tumor Cell Programmed Death Ligand 1-Mediated T Cell Suppression Is Overcome by Coexpression of CD80

Samuel Haile, Jacobus J. Bosch, Nnenna Agu et al. · The Journal of Immunology · 2011 · 85 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +22

Prognostic Significance of Tumor-Associated Lymphangiogenesis in Malignant Melanomas of the Conjunctiva

Ludwig M. Heindl, Carmen Hofmann-Rummelt, Werner Adler et al. · Ophthalmology · 2011 · 63 citations

Tumor Biology, Melanoma, Immunology +10